Difamilast Impurity 5 | CAS 2103190-58-3 - Request Quote
Difamilast Impurity 5
| SZ CAT No: | SZ-D166006 |
| CAS No | 2103190-58-3 |
| Mol.F. | C21H20F2N2O5 |
| Mol.Wt. | 418.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Difamilast Impurity 5 is chemically N-((2-(4-(difluoromethoxy)-3-isopropoxyphenyl)oxazol-4-yl)methyl)-2-hydroxybenzamide. Difamilast Impurity 5 is supplied with detailed characterization data compliant with regulatory guideline. Difamilast Impurity 5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Difamilast.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2103190-58-3
Purchase 2103190-58-3
Order 2103190-58-3
Enquire 2103190-58-3
price of 2103190-58-3
2103190-58-3 Supplier
2103190-58-3 Manufacturer
2103190-58-3 Exporter
buy high quality Difamilast Impurity 5
Purchase Difamilast Impurity 5
Difamilast Impurity 5 suppliers
Difamilast Impurity 5 manufacturers
Difamilast Impurity 5 price
Order Difamilast Impurity 5
Enquire Difamilast Impurity 5
Difamilast Impurity 5 cost
Difamilast Impurity 5 Supplier
Difamilast Impurity 5 Distributor
Difamilast Impurity 5 for Method Validation
Difamilast Reference Standard
Difamilast Impurity 5 for ANDA Filing
Difamilast Impurity 5 for Forced Degradation Studies
Difamilast Impurity 5 Identification Standards
Difamilast Impurity 5 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.